Goldman Sachs: WuXi AppTec's earnings last quarter exceeded expectations, focusing on new order momentum and clinical CRO business, target price HKD 109.6
I'm PortAI, I can summarize articles.
Goldman Sachs released a research report stating that WuXi AppTec's revenue in the third quarter reached 12.1 billion RMB, a year-on-year increase of 15.3%. The company has raised its full-year revenue guidance for 2025 to 43.5 to 44 billion RMB, and the guidance for year-on-year growth in continuing operations has been raised to 17% to 18%. Goldman Sachs has set a target price of HKD 109.6 for its Hong Kong stocks, based on a forward price-to-earnings ratio of 18 times. Management reiterated its commitment to global capacity building, and the free cash flow guidance has been raised to 8 to 8.5 billion RMB
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments